BR9706966A - Utilização do enanciômero-l de um composto e processo para tratamento ou profilaxia de câncer da mama - Google Patents
Utilização do enanciômero-l de um composto e processo para tratamento ou profilaxia de câncer da mamaInfo
- Publication number
- BR9706966A BR9706966A BR9706966A BR9706966A BR9706966A BR 9706966 A BR9706966 A BR 9706966A BR 9706966 A BR9706966 A BR 9706966A BR 9706966 A BR9706966 A BR 9706966A BR 9706966 A BR9706966 A BR 9706966A
- Authority
- BR
- Brazil
- Prior art keywords
- enanciomer
- prophylaxis
- compound
- treatment
- breast cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1000096P | 1996-01-11 | 1996-01-11 | |
| DK77696 | 1996-07-11 | ||
| PCT/DK1997/000007 WO1997025034A1 (en) | 1996-01-11 | 1997-01-09 | Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9706966A true BR9706966A (pt) | 1999-05-04 |
Family
ID=26064631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9706966A BR9706966A (pt) | 1996-01-11 | 1997-01-09 | Utilização do enanciômero-l de um composto e processo para tratamento ou profilaxia de câncer da mama |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0873119A1 (pt) |
| JP (1) | JP2001500101A (pt) |
| KR (1) | KR19990077157A (pt) |
| AU (1) | AU1367197A (pt) |
| BR (1) | BR9706966A (pt) |
| CA (1) | CA2241462A1 (pt) |
| CZ (1) | CZ217198A3 (pt) |
| HU (1) | HUP9901633A3 (pt) |
| IL (1) | IL124881A0 (pt) |
| NO (1) | NO983177L (pt) |
| PL (1) | PL328135A1 (pt) |
| WO (1) | WO1997025034A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1143899A (en) * | 1997-11-10 | 1999-05-31 | Novo Nordisk A/S | Transdermal delivery of 3,4-diarylchromans |
| AU2011253842B2 (en) * | 1998-06-11 | 2014-08-14 | Endorecherche Inc. | Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors |
| AU2004200099B2 (en) * | 1998-06-11 | 2006-11-02 | Endorecherche, Inc. | Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| JP5057983B2 (ja) | 2004-10-20 | 2012-10-24 | アンドルシェルシュ・インコーポレイテッド | 閉経後の女性における膣乾燥および性機能障害の予防および処置のための性ステロイド前駆体単独あるいは選択的エストロゲン受容体モジュレータならびに／またはエストロゲン類および／もしくは５型ｃＧＭＰホスホジエステラーゼ阻害剤の併用 |
| US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
| CA2806526C (en) | 2007-10-16 | 2014-12-30 | Repros Therapeutics Inc. | Trans-clomiphen for type 2 diabetes |
| US20100317635A1 (en) | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
| KR20170127044A (ko) | 2010-06-16 | 2017-11-20 | 앙도르쉐르슈 인코포레이티드 | 에스트로겐-관련 질병의 치료 또는 예방 방법 |
| CA2865234A1 (en) | 2012-02-29 | 2013-09-06 | Repros Therapeutics Inc. | Combination therapy for treating androgen deficiency |
| US9744177B2 (en) | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
| EP3373967B9 (en) | 2015-11-10 | 2023-10-04 | Paracrine Therapeutics AB | Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447622A (en) * | 1981-09-22 | 1984-05-08 | Council Of Scientific And Industrial Research Rafi Marg | Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof |
-
1997
- 1997-01-09 CA CA002241462A patent/CA2241462A1/en not_active Abandoned
- 1997-01-09 CZ CZ982171A patent/CZ217198A3/cs unknown
- 1997-01-09 KR KR1019980705295A patent/KR19990077157A/ko not_active Application Discontinuation
- 1997-01-09 EP EP97900199A patent/EP0873119A1/en not_active Withdrawn
- 1997-01-09 WO PCT/DK1997/000007 patent/WO1997025034A1/en not_active Application Discontinuation
- 1997-01-09 HU HU9901633A patent/HUP9901633A3/hu unknown
- 1997-01-09 JP JP09524767A patent/JP2001500101A/ja active Pending
- 1997-01-09 BR BR9706966A patent/BR9706966A/pt not_active Application Discontinuation
- 1997-01-09 IL IL12488197A patent/IL124881A0/xx unknown
- 1997-01-09 PL PL97328135A patent/PL328135A1/xx unknown
- 1997-01-09 AU AU13671/97A patent/AU1367197A/en not_active Abandoned
-
1998
- 1998-07-10 NO NO983177A patent/NO983177L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO983177L (no) | 1998-07-10 |
| KR19990077157A (ko) | 1999-10-25 |
| WO1997025034A1 (en) | 1997-07-17 |
| JP2001500101A (ja) | 2001-01-09 |
| CZ217198A3 (cs) | 1998-11-11 |
| CA2241462A1 (en) | 1997-07-17 |
| HUP9901633A3 (en) | 2000-02-28 |
| HUP9901633A2 (hu) | 1999-10-28 |
| AU1367197A (en) | 1997-08-01 |
| EP0873119A1 (en) | 1998-10-28 |
| IL124881A0 (en) | 1999-01-26 |
| PL328135A1 (en) | 1999-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9707125A (pt) | Composições e processos para o tratamento e diagnóstico de câncer de mama | |
| BR9508886A (pt) | Compostos e métodos para o tratamento de câncer | |
| BR9711530A (pt) | Combina-Æo de terapia para tratamento de psicoses | |
| PT955995E (pt) | Utilizacao de complexos para a preparacao de composicoes de tratamento para peles sensiveis, processo de preparacao e compisicoes hipoalergenicas | |
| BR9004544A (pt) | Processo de tratamento do mineral | |
| PT1062219E (pt) | Processo integrado para preparacao de complexos de dieno | |
| BR9706966A (pt) | Utilização do enanciômero-l de um composto e processo para tratamento ou profilaxia de câncer da mama | |
| BR9506271A (pt) | Processo para o tratamento de aves domésticas | |
| PT752870E (pt) | Utilizacao de mycobacterium para o tratamento de tumores | |
| PT96725A (pt) | Processo para o tratamento de graos de cacau | |
| BR9206211A (pt) | Processo para tratamento de polpa aquosa | |
| BR9006664A (pt) | Processo para preparacao de tanino insoluvel,processo para tratamento de residuos usando tanino insoluvel,e processo de adsorcao que usa tanino | |
| BR9702238A (pt) | Uso de um composto composto para uso no tratamento ou prenvenção de uma doença ou patologia envolvendo a produção de citocinas formulação farmacêutica processos de identificaç o de um composto de preparação de um composto e de tratamento ou prevenção de uma doença ou patologia envolvendo uma citocina e composto ou ligando para uso no processo de identificação | |
| GB9303210D0 (en) | Cancer treatment | |
| BR9611901A (pt) | Processo para o diagnóstico e a terapia de carcinomas epiteliais de placas | |
| PT719499E (pt) | Processo de tratamento anti-germinativo de tuberculos ou bolbos | |
| HUP9700661A3 (en) | Use of alpha-1-adrenoreceptor antagonists for the production of pharmaceuticals for profilacting and treating cancer | |
| BR9101496A (pt) | Processo para tratamento de tecidos | |
| BR9606925A (pt) | Utilização de compostos e processo para o tratamento e profilaxia da obesidade | |
| MD106B1 (ro) | Metoda de tratament a cancerului mamar | |
| BR9709752A (pt) | Processo para o tratamento ou a prevenção de dano de isquemia-reperfusão | |
| PT826814E (pt) | Processo e dispositivo para o tratamento de material fibroso | |
| PT955289E (pt) | Processo para o tratamento de materiais texteis | |
| PT822287E (pt) | Produto para tratamento de fibras | |
| ZA964387B (en) | Agent for the treatment of radiation injuries |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |